Print

Abbott Laboratories (ABT) Buy of Solvay Pharmaceuticals, Inc. Drug Unit Wins EU Approval  
2/12/2010 7:10:31 AM

Bookmark and Share

Reuters -- U.S. drugmaker Abbott Laboratories secured conditional European Union regulatory approval on Thursday for its acquisition of the drug unit of Solvay, boosting its emerging-market exposure.

//-->